These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 21867756)

  • 21. Hsp90 inhibitors reduce influenza virus replication in cell culture.
    Chase G; Deng T; Fodor E; Leung BW; Mayer D; Schwemmle M; Brownlee G
    Virology; 2008 Aug; 377(2):431-9. PubMed ID: 18570972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological evaluation of pyrimidine nucleoside monophosphate prodrugs targeted against influenza virus.
    Meneghesso S; Vanderlinden E; Stevaert A; McGuigan C; Balzarini J; Naesens L
    Antiviral Res; 2012 Apr; 94(1):35-43. PubMed ID: 22306172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of the I38T PA Substitution as a Resistance Marker for Next-Generation Influenza Virus Endonuclease Inhibitors.
    Jones JC; Kumar G; Barman S; Najera I; White SW; Webby RJ; Govorkova EA
    mBio; 2018 Apr; 9(2):. PubMed ID: 29691337
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Structural investigation of cycloheptathiophene-3-carboxamide derivatives targeting influenza virus polymerase assembly.
    Massari S; Nannetti G; Goracci L; Sancineto L; Muratore G; Sabatini S; Manfroni G; Mercorelli B; Cecchetti V; Facchini M; Palù G; Cruciani G; Loregian A; Tabarrini O
    J Med Chem; 2013 Dec; 56(24):10118-31. PubMed ID: 24313730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimization of small-molecule inhibitors of influenza virus polymerase: from thiophene-3-carboxamide to polyamido scaffolds.
    Lepri S; Nannetti G; Muratore G; Cruciani G; Ruzziconi R; Mercorelli B; Palù G; Loregian A; Goracci L
    J Med Chem; 2014 May; 57(10):4337-50. PubMed ID: 24785979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Packaging signals in the 5'-ends of influenza virus PA, PB1, and PB2 genes as potential targets to develop nucleic-acid based antiviral molecules.
    Giannecchini S; Wise HM; Digard P; Clausi V; Del Poggetto E; Vesco L; Puzelli S; Donatelli I; Azzi A
    Antiviral Res; 2011 Oct; 92(1):64-72. PubMed ID: 21741410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of influenza virus replication by constrained peptides targeting nucleoprotein.
    Jiang H; Xu Y; Li L; Weng L; Wang Q; Zhang S; Jia B; Hu H; He Y; Jacob Y; Toyoda T
    Antivir Chem Chemother; 2011 Nov; 22(3):119-30. PubMed ID: 22095520
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening methods for influenza antiviral drug discovery.
    Atkins C; Evans CW; White EL; Noah JW
    Expert Opin Drug Discov; 2012 May; 7(5):429-38. PubMed ID: 22435452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of herpesvirus and influenza virus replication by blocking polymerase subunit interactions.
    Palù G; Loregian A
    Antiviral Res; 2013 Sep; 99(3):318-27. PubMed ID: 23748148
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of a library of hybrid derivatives as inhibitors of influenza virus PA-PB1 interaction.
    D'Agostino I; Giacchello I; Nannetti G; Fallacara AL; Deodato D; Musumeci F; Grossi G; Palù G; Cau Y; Trist IM; Loregian A; Schenone S; Botta M
    Eur J Med Chem; 2018 Sep; 157():743-758. PubMed ID: 30142611
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The N terminus of PA polymerase of swine-origin influenza virus H1N1 determines its compatibility with PB2 and PB1 subunits through a strain-specific amino acid serine 186.
    Wanitchang A; Jengarn J; Jongkaewwattana A
    Virus Res; 2011 Jan; 155(1):325-33. PubMed ID: 21056603
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of a novel, first-in-class, orally bioavailable azaindole inhibitor (VX-787) of influenza PB2.
    Clark MP; Ledeboer MW; Davies I; Byrn RA; Jones SM; Perola E; Tsai A; Jacobs M; Nti-Addae K; Bandarage UK; Boyd MJ; Bethiel RS; Court JJ; Deng H; Duffy JP; Dorsch WA; Farmer LJ; Gao H; Gu W; Jackson K; Jacobs DH; Kennedy JM; Ledford B; Liang J; Maltais F; Murcko M; Wang T; Wannamaker MW; Bennett HB; Leeman JR; McNeil C; Taylor WP; Memmott C; Jiang M; Rijnbrand R; Bral C; Germann U; Nezami A; Zhang Y; Salituro FG; Bennani YL; Charifson PS
    J Med Chem; 2014 Aug; 57(15):6668-78. PubMed ID: 25019388
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peptide-mediated interference with influenza A virus polymerase.
    Ghanem A; Mayer D; Chase G; Tegge W; Frank R; Kochs G; García-Sastre A; Schwemmle M
    J Virol; 2007 Jul; 81(14):7801-4. PubMed ID: 17494067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of the antiviral drug susceptibility of influenza viruses in Italy from 2004/05 to 2009/10 epidemics and from the recent 2009 pandemic.
    Puzelli S; Facchini M; Di Martino A; Fabiani C; Lackenby A; Zambon M; Donatelli I
    Antiviral Res; 2011 Jun; 90(3):205-12. PubMed ID: 21514326
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of Hsp90 in assembly and nuclear import of influenza virus RNA polymerase subunits.
    Naito T; Momose F; Kawaguchi A; Nagata K
    J Virol; 2007 Feb; 81(3):1339-49. PubMed ID: 17121807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an HTS assay for the search of anti-influenza agents targeting the interaction of viral RNA with the NS1 protein.
    Maroto M; Fernandez Y; Ortin J; Pelaez F; Cabello MA
    J Biomol Screen; 2008 Aug; 13(7):581-90. PubMed ID: 18594021
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein-protein interactions as targets for antiviral chemotherapy.
    Loregian A; Marsden HS; Palù G
    Rev Med Virol; 2002; 12(4):239-62. PubMed ID: 12125015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influenza A virus polymerase: an attractive target for next-generation anti-influenza therapeutics.
    Zhou Z; Liu T; Zhang J; Zhan P; Liu X
    Drug Discov Today; 2018 Mar; 23(3):503-518. PubMed ID: 29339107
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protein-Structure Assisted Optimization of 4,5-Dihydroxypyrimidine-6-Carboxamide Inhibitors of Influenza Virus Endonuclease.
    Beylkin D; Kumar G; Zhou W; Park J; Jeevan T; Lagisetti C; Harfoot R; Webby RJ; White SW; Webb TR
    Sci Rep; 2017 Dec; 7(1):17139. PubMed ID: 29215062
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The substances active against influenza virus. Possibilities and prospects of application].
    Kwiatek M; Kocik J; Bartoszcze M
    Przegl Epidemiol; 2009; 63(4):487-94. PubMed ID: 20120945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.